Biomedical Catalyst 2016 – Feasibility Studies

Key Features

UK businesses can apply for a share of up to £10 million to develop innovative ideas that will help solve healthcare challenges.

Programme:     Innovate UK

Award:     Up to £140k

Opens: 4th Jul 2016

Closes: 14th Sep 2016

! This scheme is now closed

The aim of this competition is to develop innovative healthcare technologies and processes that will help provide:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

The aim of this competition is to explore and test the commercial potential of early-stage ideas through:

  • reviewing research evidence and identifying possible applications
  • assessing business opportunities
  • investigating intellectual property issues
  • validating initial concepts or existing pre-clinical work through experimental studies
  • identifying areas for further development

The aim of this competition is to explore and test the commercial potential of early-stage ideas through:

  • reviewing research evidence and identifying possible applications
  • assessing business opportunities
  • investigating intellectual property issues
  • validating initial concepts or existing pre-clinical work through experimental studies
  • identifying areas for further development

These ideas should be for innovative healthcare technologies and processes that will help provide:

  • disease prevention and proactive management of health and chronic conditions
  • earlier and better detection and diagnosis of disease leading to better patient outcomes
  • tailored treatments that either change the underlying disease or offer potential cures

Exclusions

In this competition we won’t fund projects which:

  • we think are too early stage – for example basic research, generation of pure scientific and technological knowledge, the development of research ideas, hypotheses and experimental designs without application
  • we think are too closed to market or are already at market – for example evaluations to inform labelling, approval of pharmaceutical/device by relevant authorities, laboratory accreditation, distribution or marketing activity, post-marketing studies and post-marketing surveillance

Funding Costs

We have allocated up to £2 million to fund innovation projects in this competition.

You could get up to:

  • 70% of your eligible project costs if you are a small or micro business
  • 60% if you are a medium-sized business

Check if your business fits the EU definition of an SME

We expect projects to last between 3 months and 1 year. Projects must start by 1 January 2017 and end by 1 January 2018. The maximum project size is £200,000.